Telehealth providers will soon offer more affordable access to weight loss drug Wegovy, according to manufacturer Novo ...

Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...

Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of ...

The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

The stock (HIMS) soared 24.2% in midday trading toward a one-month closing high. It's on track the biggest one-day gain since it ran up 27.7% on Feb. 13, 2025. That rally was part of a big surge to ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

Novo Nordisk collaborates with telehealth companies to expand sales and access to its weight-loss drug Wegovy, amidst efforts ...

Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week ...

Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...